HRS4R
Vull donar
Firma
RAFEL MARCOS-GRAGERA
Posició
Cap de Grup - R4
Caps de Grup - R4

Projectes

Codi oficial: 6822ZB3KJ Data inici: 01/01/2022 Data fi: 30/06/2025 Investigador/a principal: DAVID GALLARDO GIRALT Organisme finançador: AGÈNCIA DE GESTIÓ UNIVERSITARIS I RECERCA
Codi oficial: 101128640 Data inici: 01/01/2024 Data fi: 31/12/2026 Investigador/a principal: RAFEL MARCOS GRAGERA Organisme finançador: EUROPEAN COMISSION

Publicacions

Bouvier, AM, Jooste, V, Lillini, R, Marcos-Gragera, R, Katalinic, A, Rossi, PG, Launoy, G, Bouvier, V, Guevara, M, Ardanaz, E, Aylward, ER, Innos, K, Barranco, MR, Sant, M

Differences in survival and recurrence of colorectal cancer by stage across population-based European registries

INTERNATIONAL JOURNAL OF CANCER, 2024, 155, 807-815 dx.doi.org/10.1002/ijc.34944
Trama, A, Botta, L, Stiller, C, Visser, O, Cañete-Nieto, A, Spycher, B, Bielska-Lasota, M, Katalinic, A, Vener, C, Innos, K, Marcos-Gragera, R, Paapsi, K, Guevara, M, Demuru, E, Mousavi, SM, Blum, M, Eberle, A, Ferrari, A, Bernasconi, A, Lasalvia, P

Survival of European adolescents and young adults diagnosed with cancer in 2010-2014

EUROPEAN JOURNAL OF CANCER, 2024, 202, 113558-113558 dx.doi.org/10.1016/j.ejca.2024.113558
Botta, L, Capocaccia, R, Bernasconi, A, Rossi, S, Galceran, J, Dal Maso, L, Lepage, C, Molinié, F, Bouvier, AM, Marcos-Gragera, R, Vener, C, Guevara, M, Murray, D, Ragusa, R, Gatta, G, Jooste, V

Estimating cure and risk of death from other causes of cancer patients: EUROCARE-6 data on head & neck, colorectal, and breast cancers

EUROPEAN JOURNAL OF CANCER, 2024, 208, 114187-114187 dx.doi.org/10.1016/j.ejca.2024.114187
Teixidor-Vilà E, Trallero J, Puigdemont M, Vidal-Vila A, Hernandez-Martínez A, Sais E, Sabaté-Ortega J, Verdura S, Menendez JA, Bosch-Barrera J, Sanvisens A, Marcos-Gragera R

Lung cancer survival trends and prognostic factors: A 26-year population-based study in Girona Province, Spain.

LUNG CANCER, 2024, 197, 107995-107995 dx.doi.org/10.1016/j.lungcan.2024.107995
Cubelos-Fernández N, Dávila-Batista V, Fernández-Villa T, Castaño-Vinyals G, Perez-Gomez B, Amiano P, Ardanaz E, Delgado Sillero I, Llorca J, Tardón GF, Alguacil J, Vanaclocha Espí M, Marcos-Gragera R, Moreno V, Aragones N, Dorronsoro A, Guevara M, Reguero Celada S, Pollan M, Kogevinas M, Martín V

Burden of postmenopausal breast cancer attributable to excess body weight: comparative study of body mass index and CUN-BAE in MCC-Spain study.

JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2024, 79, 64-71 dx.doi.org/10.1136/jech-2023-220706
Girardi F, Matz M, Stiller C, You H, Marcos Gragera R, Valkov MY, Bulliard JL, De P, Morrison D, Wanner M, O'Brian DK, Saint-Jacques N, Coleman MP, Allemani C, CONCORD Working Group

Global survival trends for brain tumors, by histology: analysis of individual records for 556,237 adults diagnosed in 59 countries during 2000-2014 (CONCORD-3)

Neuro-Oncology, 2023, 25, 580-592 dx.doi.org/10.1093/neuonc/noac217
Clèries R, Ameijide A, Buxó M, Vilardell M, Martínez JM, Font R, Marcos-Gragera R, Puigdemont M, Viñas G, Carulla M, Espinàs JA, Galceran J, Izquierdo Á, Borràs JM

Ten-Year Probabilities of Death Due to Cancer and Cardiovascular Disease among Breast Cancer Patients Diagnosed in North-Eastern Spain

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2023, 20 dx.doi.org/10.3390/ijerph20010405
Giusti F, Martos C, Trama A, Bettio M, Sanvisens A, Audisio R, Arndt V, Francisci S, Dochez C, Ribes J, Fernández LP, Gavin A, Gatta G, Marcos-Gragera R, Lievens Y, Allemani C, De Angelis R, Visser O, Van Eycken L

Cancer treatment data available in European cancer registries: Where are we and where are we going?

Frontiers in oncology, 2023, 13, 1109978-1109978 dx.doi.org/10.3389/fonc.2023.1109978
Auñón C, Sanvisens A, Turon E, Vidal-Vila A, Puigdemont M, Osca-Gelis G, Eraso A, Marcos-Gragera R

Time trends and survival of marginal zone lymphoma over 25 years in Girona, Spain (1994-2018)

CANCER MEDICINE, 2023, 12, 12343-12353 dx.doi.org/10.1002/cam4.5935
Cabrera-Serrano AJ, Sánchez-Maldonado JM, Ter Horst R, Macauda A, García-Martín P, Benavente Y, Landi S, Clay-Gilmour A, Niazi Y, Espinet B, Rodríguez-Sevilla JJ, Pérez EM, Maffei R, Blanco G, Giaccherini M, Cerhan JR, Marasca R, López-Nevot MÁ, Chen-Liang T, Thomsen H, Gámez I, Campa D, Moreno V, de Sanjosé S, Marcos-Gragera R, García-Álvarez M, Dierssen-Sotos T, Jerez A, Butrym A, Norman AD, Luppi M, Slager SL, Hemminki K, Li Y, Berndt SI, Casabonne D, Alcoceba M, Puiggros A, Netea MG, Försti A, Canzian F, Sainz J

Do GWAS-Identified Risk Variants for Chronic Lymphocytic Leukemia Influence Overall Patient Survival and Disease Progression?

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 dx.doi.org/10.3390/ijms24098005

Formulari de contacte

Coneix l’IDIBGI!

menu